Clinical trial

Clozapine-related Immunodeficiency in Parkinsons Disease

NCT06634641

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-10-01

PhasePHASE4

Study timeline

Study start (actual)2024-10-01Date precision: day

Registry last updated2025-11-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Clozapineunresolved

Parkinson's Disease (PD)unresolved

Immunodeficiencyunresolved

Psychosisunresolved

Interventions

blood testBIOLOGICAL

Sponsors & collaborators

Centre Hospitalier Universitaire, Amienslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06634641 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.